Adjusted 1 | Total | Adjusted 1 | Total | ||||
| 2025 | Adjustments 1 | 2025 | 2024 | Adjustments 1 | 2024 | ||
| Note | £m | £m | £m | £m | £m | £m | |
Revenue | 3,4 | ||||||
Operating expenses | 2 | ( | ( | ( | ( | ( | ( |
Operating profit | ( | ( | |||||
Financial expense, net | 6 | ( | ( | ( | ( | ( | ( |
Profit before tax | ( | ( | |||||
Tax expense | 7 | ( | ( | ( | ( | ||
Profit for the year | ( | ( | |||||
| Attributable to: | |||||||
Shareholders of the Company | ( | ( | |||||
Minority interests | 21 | ||||||
( | ( | ||||||
| Earnings per share (p) | |||||||
Adjusted/Basic earnings | 9 | ||||||
Adjusted/Diluted earnings | 9 |
| 2025 | 2024 | ||
| Note | £m | £m | |
Profit for the year | |||
| Items that will not be reclassified to the Consolidated Income Statement | |||
Actuarial loss on the defined benefit pension schemes | 25 | ( | ( |
Deferred tax on items that will not be reclassified | 7,14 | ||
( | ( | ||
| Items that may be reclassified to the Consolidated Income Statement | |||
Exchange differences on translation of foreign operations | ( | ||
Recycling of foreign exchange reserve and net investment hedging on disposal of businesses | ( | ||
Exchange differences on translation of net investment hedge | 19 | ( | |
Fair value losses/(gains) of cash flow hedges transferred from the hedging reserve | 19 | ( | |
Gains/(losses) on fair value of cash flow hedges | 19 | ( | |
Deferred tax on items that may be reclassified | 7,14 | ||
( | ( | ||
Total Other Comprehensive Income | ( | ( | |
Total Comprehensive Income for the year | |||
| Attributable to: | |||
Shareholders of the Company | |||
Minority interests | |||
| Share | Share | Translation | Hedging | Retained | Shareholders’ | Minority | Total | ||
| capital | premium | reserve | reserve | earnings | equity | interests | equity | ||
| Note | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 October 2023 | |||||||||
Total Comprehensive Income | ( | ( | |||||||
Share-based payments | 5 | ||||||||
Tax on items recognised directly in equity | 7 | ||||||||
Notional purchase of own shares | ( | ( | ( | ||||||
Dividends | 8,21 | ( | ( | ( | ( | ||||
At 30 September 2024 | ( | ( | |||||||
Total Comprehensive Income | ( | ||||||||
Share-based payments | 5 | ||||||||
Disposal of business | 21 | ( | ( | ||||||
Purchase of minority interest | 21 | ( | |||||||
Tax on items recognised directly in equity | 7 | ||||||||
Notional purchase of own shares | ( | ( | ( | ||||||
Dividends | 8,21 | ( | ( | ( | ( | ||||
At 30 September 2025 | ( |
| 2025 | 2024 | ||
| Note | £m | £m | |
| Non-current assets | |||
Goodwill | 10 | ||
Acquisition intangible assets | 11 | ||
Other intangible assets | 11 | ||
Property, plant and equipment | 12 | ||
Leases – right-of-use assets | 13 | ||
Other financial assets | 19 | ||
Retirement benefit assets | 25 | ||
Deferred tax assets | 14 | ||
| Current assets | |||
Inventories | 15 | ||
Trade and other receivables | 16 | ||
Assets held for sale | |||
Cash and cash equivalents | 18 | ||
| Current liabilities | |||
Borrowings | 24 | ( | |
Trade and other payables | 17 | ( | ( |
Liabilities held for sale | ( | ||
Current tax liabilities | 7 | ( | ( |
Other liabilities | 20 | ( | ( |
Lease liabilities | 13 | ( | ( |
( | ( | ||
Net current assets | |||
Total assets less current liabilities |
| 2025 | 2024 | ||
| £m | £m | ||
| Non-current liabilities | |||
Borrowings | 24 | ( | ( |
Trade and other payables | 17 | ( | ( |
Lease liabilities | 13 | ( | ( |
Other liabilities | 20 | ( | ( |
Deferred tax liabilities | 14 | ( | ( |
( | ( | ||
Net assets | |||
| Equity | |||
Share capital | |||
Share premium | |||
Translation reserve | ( | ( | |
Hedging reserve | ( | ||
Retained earnings | |||
Total shareholders’ equity | |||
Minority interests | 21 | ||
Total equity |
| 2025 | 2024 | ||
| Note | £m | £m | |
Operating profit | |||
Acquisition related and other charges | |||
Non-cash items and other | |||
Increase in working capital | ( | ( | |
Cash flow from operating activities | 23 | ||
Interest paid, net (including borrowing fees) | ( | ( | |
Tax paid | ( | ( | |
Net cash inflow from operating activities | |||
| Cash flow from investing activities | |||
Acquisition of businesses (net of cash acquired) | ( | ( | |
Acquisition related deferred (payments)/receipts, net | ( | ( | |
Proceeds from sale of business (net of cash disposed) | |||
Purchase of property, plant and equipment | 12 | ( | ( |
Purchase of other intangible assets | 11 | ( | ( |
Proceeds from sale of property, plant and equipment | |||
Net cash used in investing activities | ( | ( |
| 2025 | 2024 | ||
| Note | £m | £m | |
| Cash flow from financing activities | |||
Dividends paid to shareholders | 8 | ( | ( |
Dividends paid to minority interests | 21 | ( | ( |
Acquisition of minority interest | ( | ||
| Notional purchase of own shares on exercise | |||
ofshareoptions | ( | ( | |
Proceeds from borrowings | |||
Repayment of borrowings | ( | ( | |
Principal elements of lease payments | ( | ( | |
Net cash (outflow)/inflow from financing activities | ( | ||
Net increase/(decrease) in cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of year | |||
Effect of exchange rates on cash and cash equivalents | ( | ||
| Cash and cash equivalents including cash held in disposal | |||
groups at the end of the year | |||
Cash and cash equivalents held in disposal groups | 24 | ( | |
Cash and cash equivalents at end of year | 18 |
| Adjusted | Total | Adjusted | Total | |||
| 2025 | Adjustments | 2025 | 2024 | Adjustments | 2024 | |
| £m | £m | £m | £m | £m | £m | |
Cost of inventories sold | 812.7 | 5.7 | 818.4 | 730.1 | 4.4 | 734.5 |
Employee costs (note 5) | 237.0 | 4.9 | 241.9 | 230.9 | 3.9 | 234.8 |
Depreciation of property, plant and equipment (note 12) | 14.2 | — | 14.2 | 14.6 | — | 14.6 |
Depreciation of right-of-use assets | ||||||
(note 13) | 15.5 | — | 15.5 | 16.3 | — | 16.3 |
Amortisation (note 11) | 0.8 | 61.7 | 62.5 | 1.3 | 59.4 | 60.7 |
| Net impairment | ||||||
| movements on trade | ||||||
receivables (note 16) | 1.2 | — | 1.2 | (0.6) | — | (0.6) |
| Other operating | ||||||
expenses/(income) | 100.4 | (13.3) | 87.1 | 85.8 | 9.9 | 95.7 |
Operating expenses | 1,181.8 | 59.0 | 1,240.8 | 1,078.4 | 77.6 | 1,156.0 |
Controls | Seals | Life Sciences | Corporate | Group | ||||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
| £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Revenue – existing 1 | 833.5 | 652.4 | 454.3 | 489.1 | 225.8 | 221.9 | — | — | 1,513.6 | 1,363.4 |
Revenue – acquisitions 1 | 2.9 | — | 1.7 | — | 6.3 | — | — | — | 10.9 | — |
Revenue | 836.4 | 652.4 | 456.0 | 489.1 | 232.1 | 221.9 | — | — | 1,524.5 | 1,363.4 |
Cost of inventories sold – existing 1 | (458.1) | (373.3) | (223.8) | (238.6) | (129.6) | (122.6) | — | — | (811.5) | (734.5) |
Cost of inventories sold – acquisitions 1 | (2.0) | — | (1.0) | — | (3.9) | — | — | — | (6.9) | — |
Cost of inventories sold | (460.1) | (373.3) | (224.8) | (238.6) | (133.5) | (122.6) | — | — | (818.4) | (734.5) |
Adjusted operating profit – existing 1 | 250.5 | 169.9 | 87.8 | 90.7 | 44.0 | 46.8 | (41.3) | (22.4) | 341.0 | 285.0 |
Adjusted operating profit – acquisitions 1 | 0.1 | — | 0.3 | — | 1.3 | — | — | — | 1.7 | — |
Adjusted operating profit | 250.6 | 169.9 | 88.1 | 90.7 | 45.3 | 46.8 | (41.3) | (22.4) | 342.7 | 285.0 |
Acquisition related and other charges | (39.4) | ( 37.6) | (9.1) | (28.5) | (10.5) | (11.5) | — | — | (59.0) | ( 7 7.6) |
Operating profit | 211.2 | 132.3 | 79.0 | 62.2 | 34.8 | 35.3 | (41.3) | (22.4) | 283.7 | 207.4 |
Operating assets | 343.6 | 301.6 | 216.5 | 262.9 | 104.2 | 94.2 | — | — | 664.3 | 658.7 |
Other financial assets | — | — | — | — | 1.5 | — | — | — | 1.5 | — |
Goodwill | 267.6 | 265.3 | 185.1 | 179.1 | 110.8 | 96.7 | — | — | 563.5 | 541.1 |
Acquisition intangible assets | 239.7 | 268.4 | 172.0 | 183.4 | 67.4 | 56.0 | — | — | 479.1 | 507.8 |
850.9 | 835.3 | 573.6 | 625.4 | 283.9 | 246.9 | — | — | 1,708.4 | 1,707.6 | |
| Unallocated assets: | ||||||||||
– Deferred tax assets | 9.7 | 0.9 | 9.7 | 0.9 | ||||||
– Cash and cash equivalents | 81.7 | 55.5 | 81.7 | 55.5 | ||||||
– Acquisition related assets | 2.0 | 1.8 | 2.0 | 1.8 | ||||||
– Retirement benefit assets | 1.7 | 1.5 | 1.7 | 1.5 | ||||||
– Corporate assets | 5.9 | 4.8 | 5.9 | 4.8 | ||||||
Total assets | 850.9 | 835.3 | 573.6 | 625.4 | 283.9 | 246.9 | 101.0 | 64.5 | 1,809.4 | 1,772.1 |
Controls | Seals | Life Sciences | Corporate | Group | ||||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
| £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Operating liabilities | (166.6) | (120.7) | (100.5) | ( 119.2) | (55.5) | (52.1) | — | — | (322.6) | (292.0) |
| Unallocated liabilities: | ||||||||||
– Deferred tax liabilities | (44.9) | (49.5) | (44.9) | (49.5) | ||||||
– Acquisition related liabilities | (26.7) | (25.4) | (26.7) | (25.4) | ||||||
– Corporate liabilities | (39.9) | (30.7) | (39.9) | (30.7) | ||||||
– Borrowings | (381.1) | (479.8) | (381.1) | (479.8) | ||||||
Total liabilities | (166.6) | (120.7) | (100.5) | ( 119.2) | (55.5) | (52.1) | (492.6) | (585.4) | (815.2) | (877.4) |
Net assets/(liabilities) | 684.3 | 714.6 | 473.1 | 506.2 | 228.4 | 194.8 | (391.6) | (520.9) | 994.2 | 894.7 |
Controls | Seals | Life Sciences | Corporate | Group | ||||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
| £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Capital expenditure | 2.3 | 5.7 | 4.8 | 4.7 | 7.2 | 9.2 | 0.1 | 0.1 | 14.4 | 19.7 |
Depreciation and amortisation | 4.9 | 5.0 | 4.5 | 6.1 | 5.3 | 4.5 | 0.3 | 0.3 | 15.0 | 15.9 |
| Revenue recognition | ||||||||||
– immediately on sale | 826.7 | 642.2 | 438.8 | 465.3 | 216.5 | 207.3 | — | — | 1,482.0 | 1,314.8 |
– over a period of time | 9.7 | 10.2 | 17.2 | 23.8 | 15.6 | 14.6 | — | — | 42.5 | 48.6 |
836.4 | 652.4 | 456.0 | 489.1 | 232.1 | 221.9 | — | — | 1,524.5 | 1,363.4 |
Revenue | Adjusted operating profit | Non-current assets 1 | Trading capital employed | Capital expenditure | ||||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
| £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
United Kingdom 2 | 279.8 | 273.0 | 8.6 | 23.3 | 260.0 | 242.4 | 219.4 | 229.3 | 2.4 | 4.9 |
Rest of Europe | 247.5 | 267.8 | 48.3 | 53.9 | 287.7 | 264.9 | 326.9 | 321.4 | 2.5 | 2.3 |
USA | 802.6 | 626.1 | 248.5 | 165.5 | 543.1 | 566.9 | 691.4 | 698.2 | 2.2 | 3.6 |
Rest of world | 194.6 | 196.5 | 37.3 | 42.3 | 99.1 | 106.6 | 114.1 | 136.1 | 7.3 | 8.9 |
1,524.5 | 1,363.4 | 342.7 | 285.0 | 1,189.9 | 1,180.8 | 1,351.8 | 1,385.0 | 14.4 | 19.7 |
2025 | 2024 | |
Controls | 1,170 | 1,110 |
Seals | 1,668 | 1,824 |
Life Sciences | 493 | 463 |
Corporate | 44 | 42 |
Number of employees – average | 3,375 | 3,439 |
Number of employees – year end | 3,390 | 3,597 |
| 2025 | 2024 | |
| £m | £m | |
Wages and salaries | 208.0 | 200.8 |
Social security costs | 19.5 | 18.5 |
Other pension costs | 8.2 | 8.4 |
Share-based payments | 6.2 | 7.1 |
241.9 | 234.8 |
| 2025 | 2024 | |
| £m | £m | |
Salaries and short-term employee benefits | 8.2 | 7.2 |
Pension costs | 0.2 | 0.2 |
Share-based payments | 4.5 | 5.2 |
12.9 | 12.6 |
| 2025 | 2024 | |
| £m | £m | |
Non-Executive Directors | 0.8 | 0.7 |
Executive Directors | 3.5 | 3.1 |
4.3 | 3.8 |
| 2025 | 2024 | |
| £m | £m | |
| Interest expense/(income) and similar charges | ||
– bank facility and commitment fees | 2.3 | 1.7 |
– interest income on short-term deposits | (0.7) | (0.6) |
– interest expense on borrowings | 21.8 | 22.2 |
| – notional interest income on the defined benefit pension scheme | ||
(note 25) | (0.1) | (0.3) |
– amortisation of capitalised borrowing fees | 0.1 | 0.1 |
– interest on lease liabilities (note 13) | 3.9 | 3.9 |
Net interest expense and similar charges | 27. 3 | 27.0 |
– acquisition related finance charges, net | 8.1 | 3.8 |
Financial expense, net | 35.4 | 30.8 |
| 2025 | 2024 | |
| £m | £m | |
| Current tax | ||
| The tax charge is based on the profit for the year and comprises: | ||
UK corporation tax | 25.2 | 15.2 |
Overseas tax | 61.6 | 40.1 |
86.8 | 55.3 | |
| Adjustments in respect of prior year: | ||
UK corporation tax | (2.1) | (0.2) |
Overseas tax | (2.2) | 0.4 |
Total current tax | 82.5 | 55.5 |
| Deferred tax | ||
| The net deferred tax credit based on the origination and reversal | ||
| of timing differences comprises: | ||
United Kingdom | (5.0) | (1.2) |
Overseas | (14.7) | (7.7) |
Total deferred tax | (19.7 ) | (8.9) |
Total tax on profit for the year | 62.8 | 46.6 |
| 2025 | 2024 | |
| £m | £m | |
Profit before tax | 248.3 | 176.6 |
Tax on profit at UK effective corporation tax rate of 25.0% (2024: 25.0%) | 62.1 | 44.2 |
| Effects of: | ||
overseas tax rates | 0.7 | 0.4 |
adjustments in respect of UK and Overseas corporation tax in prior years | (4.3) | 0.2 |
other permanent differences | 4.3 | 1.8 |
Total tax on profit for the year | 62.8 | 46.6 |
Tax effect on adjusting items | 16.0 | 15.3 |
Adjusted tax expense | 78.8 | 61.9 |
| 2025 | 2024 | |||
| pence | pence | 2025 | 2024 | |
| per share | per share | £m | £m | |
Interim dividend, paid in June | 18.2 | 17.3 | 24.4 | 23.2 |
Final dividend of the prior year, paid in January | 42.0 | 40.0 | 56.3 | 53.6 |
60.2 | 57.3 | 80.7 | 76.8 |
| 2025 | 2025 | 2024 | 2024 | |||
| pence | pence | pence | pence | |||
| per share | per share | per share | per share | 2025 | 2024 | |
| Basic | Diluted | Basic | Diluted | £m | £m | |
Profit before tax | 248.3 | 176.6 | ||||
Tax expense | (62.8) | (46.6) | ||||
Minority interests | (0.6) | (0.7) | ||||
Earnings for the year attributable to shareholders of the Company | 137.9 | 13 7.3 | 96.5 | 96.1 | 184.9 | 129.3 |
Acquisition related and other charges and acquisition related | ||||||
| finance charges, net | ||||||
of tax | 38.1 | 38.0 | 49.3 | 49.2 | 51.1 | 66.1 |
Adjusted earnings | 176.0 | 175.3 | 145.8 | 145.3 | 236.0 | 195.4 |
| Life | ||||
| Controls | Seals | Sciences | Total | |
| £m | £m | £m | £m | |
At 1 October 2023 | 167. 3 | 169.4 | 102.4 | 439.1 |
Acquisitions | 118.1 | 27.0 | — | 145.1 |
Transfers to Held for Sale Assets | (0.6) | (11.8) | — | (12.4) |
Exchange adjustments | ( 19.5) | (5.5) | (5.7) | (30.7) |
At 30 September 2024 | 265.3 | 179.1 | 96.7 | 541.1 |
Acquisitions (note 22) | 2.6 | 5.2 | 13.4 | 21.2 |
Disposals | — | (0.5) | — | (0.5) |
Exchange adjustments | (0.3) | 1.3 | 0.7 | 1.7 |
At 30 September 2025 | 267.6 | 185.1 | 110.8 | 563.5 |
| Customer | Total | |||||
| relationships | Trade | acquisition | Other | |||
| and order | Supplier | names and | intangible | intangible | ||
| backlog | relationships | brands | Technology | assets | assets | |
| £m | £m | £m | £m | £m | £m | |
| Cost | ||||||
At 1 October 2023 | 653.9 | 29.3 | 55.5 | 0.7 | 739.4 | 10.2 |
Additions | — | — | — | — | — | 0.8 |
Acquisitions | 83.7 | — | — | — | 83.7 | — |
Disposals | — | — | — | — | — | (0.4) |
Transfers to Held for Sale Assets | ( 17.5) | (1.4) | — | — | (18.9) | (1.5) |
Exchange adjustments | (41.4) | (1.5) | (4.3) | — | (47.2) | (0.6) |
At 30 September 2024 | 678.7 | 26.4 | 51.2 | 0.7 | 757.0 | 8.5 |
Additions | — | — | — | — | — | 1.0 |
Acquisitions (Note 22) | 27.3 | — | — | — | 27.3 | 0.2 |
Disposals | (0.8) | — | — | — | (0.8) | (0.2) |
Exchange adjustments | 6.2 | (0.2) | 0.1 | — | 6.1 | — |
At 30 September 2025 | 711.4 | 26.2 | 51.3 | 0.7 | 789.6 | 9.5 |
| Customer | Total | |||||
| relationships | Trade | acquisition | Other | |||
| and order | Supplier | names and | intangible | intangible | ||
| backlog | relationships | brands | Technology | assets | assets | |
| £m | £m | £m | £m | £m | £m | |
| Amortisation | ||||||
At 1 October 2023 | 176.7 | 25.1 | 17. 5 | — | 219.3 | 6.0 |
Acquisitions | 4.0 | — | — | — | 4.0 | — |
Charge for the year | 47.7 | 1.7 | 5.9 | 0.1 | 55.4 | 1.3 |
Disposals | — | — | — | — | — | (0.3) |
Transfers to Held for Sale Assets | (13.8) | (1.4) | — | — | (15.2) | (0.8) |
Exchange adjustments | (11.3) | (1.3) | (1.7) | — | (14.3) | (0.3) |
At 30 September 2024 | 203.3 | 24.1 | 21.7 | 0.1 | 249.2 | 5.9 |
Acquisitions | 0.6 | — | — | — | 0.6 | — |
Charge for the year | 54.4 | 0.7 | 5.9 | 0.1 | 61.1 | 0.8 |
Disposals | (0.2) | — | — | — | (0.2) | (0.2) |
Exchange adjustments | (0.1) | — | (0.1) | — | (0.2) | — |
At 30 September 2025 | 258.0 | 24.8 | 2 7.5 | 0.2 | 310.5 | 6.5 |
| Net book value | ||||||
At 30 September 2025 | 453.4 | 1.4 | 23.8 | 0.5 | 479.1 | 3.0 |
At 30 September 2024 | 475.4 | 2.3 | 29.5 | 0.6 | 507.8 | 2.6 |
| Economic life | |
Customer relationships | 5–16 years |
Supplier relationships | 8–10 years |
Trade names and brands | 5–11 years |
Technology | 5 years |
Order backlog | 3 years |
| Freehold | Leasehold | Plant and | Hospital field | ||
| properties | improvements | equipment | equipment | Total | |
| £m | £m | £m | £m | £m | |
| Cost | |||||
At 1 October 2023 | 3.1 | 17.6 | 67.3 | 24.9 | 112.9 |
Additions | 0.2 | 1.7 | 9.7 | 7.3 | 18.9 |
| Acquisition of businesses | 4.1 | 4.9 | 0.3 | — | 9.3 |
Disposals | (0.8) | (1.5) | (3.2) | (1.1) | (6.6) |
Transfers to Held for Sale Assets | — | (0.4) | (7. 5) | — | ( 7.9) |
Exchange adjustments | (0.2) | (1.6) | (5.6) | (2.1) | (9.5) |
At 30 September 2024 | 6.4 | 20.7 | 61.0 | 29.0 | 117.1 |
Additions | 0.2 | 2.1 | 5.1 | 6.0 | 13.4 |
| Acquisition of businesses (note 22) | 4.2 | 0.1 | 0.8 | 0.2 | 5.3 |
Disposals | (0.1) | (0.9) | (2.2) | (1.0) | (4.2) |
Exchange adjustments | — | 0.4 | 0.5 | (1.3) | (0.4) |
At 30 September 2025 | 10.7 | 22.4 | 65.2 | 32.9 | 131.2 |
| Freehold | Leasehold | Plant and | Hospital field | ||
| properties | improvements | equipment | equipment | Total | |
| £m | £m | £m | £m | £m | |
| Depreciation | |||||
At 1 October 2023 | 0.8 | 5.6 | 35.6 | 11.7 | 53.7 |
Charge for the year | 0.1 | 1.6 | 9.1 | 3.8 | 14.6 |
Disposals | (0.7) | (0.3) | (2.3) | (0.5) | (3.8) |
Transfers to Held for Sale Assets | — | (0.1) | (4.8) | — | (4.9) |
Exchange adjustments | — | (0.5) | (4.4) | (1.0) | (5.9) |
At 30 September 2024 | 0.2 | 6.3 | 33.2 | 14.0 | 53.7 |
Charge for the year | 0.1 | 1.8 | 7.8 | 4.5 | 14.2 |
Disposals | — | (0.6) | (2.1) | (0.3) | (3.0) |
Exchange adjustments | — | 0.3 | 0.1 | (0.8) | (0.4) |
At 30 September 2025 | 0.3 | 7.8 | 39.0 | 17.4 | 64.5 |
| Net book value | |||||
At 30 September 2025 | 10.4 | 14.6 | 26.2 | 15.5 | 66.7 |
At 30 September 2024 | 6.2 | 14.4 | 27.8 | 15.0 | 63.4 |
| Land & | Plant & | Motor | IT & office | ||
| buildings | machinery | vehicles | equipment | Total | |
| £m | £m | £m | £m | £m | |
| Cost | |||||
At 1 October 2023 | 100.9 | 0.8 | 9.9 | 2.0 | 113.6 |
Additions | 16.9 | 0.2 | 3.2 | 0.1 | 20.4 |
Disposals | (5.3) | (0.1) | (1.6) | — | (7.0) |
Transfers to Held for Sale Assets | (8.4) | — | (0.7) | — | (9.1) |
Exchange adjustments | (8.3) | — | (2.0) | (0.9) | (11.2) |
At 30 September 2024 | 95.8 | 0.9 | 8.8 | 1.2 | 106.7 |
Additions | 23.3 | 0.1 | 3.8 | 0.1 | 27. 3 |
Disposals | (3.3) | (0.1) | (3.7) | (0.2) | ( 7.3) |
Exchange adjustments | (0.3) | — | 0.2 | 0.1 | — |
At 30 September 2025 | 115.5 | 0.9 | 9.1 | 1.2 | 126.7 |
| Land & | Plant & | Motor | IT & office | ||
| buildings | machinery | vehicles | equipment | Total | |
| £m | £m | £m | £m | £m | |
| Depreciation | |||||
At 1 October 2023 | 36.0 | 0.3 | 4.5 | 1.3 | 42.1 |
Charge for the year | 13.7 | 0.2 | 2.2 | 0.2 | 16.3 |
Disposals | (4.3) | (0.1) | (1.4) | — | (5.8) |
Transfers to Held for Sale Assets | (2.7) | — | (0.4) | — | (3.1) |
Exchange adjustments | (6.5) | — | (1.4) | (0.8) | (8.7) |
At 30 September 2024 | 36.2 | 0.4 | 3.5 | 0.7 | 40.8 |
Charge for the year | 12.7 | 0.2 | 2.4 | 0.2 | 15.5 |
Disposals | (3.1) | (0.1) | (2.3) | (0.2) | (5.7) |
Exchange adjustments | (0.3) | — | 0.2 | 0.1 | — |
At 30 September 2025 | 45.5 | 0.5 | 3.8 | 0.8 | 50.6 |
| Net book value | |||||
At 30 September 2025 | 70.0 | 0.4 | 5.3 | 0.4 | 76.1 |
At 30 September 2024 | 59.6 | 0.5 | 5.3 | 0.5 | 65.9 |
| 2025 | 2024 | |
| £m | £m | |
At 1 October | 72.3 | 80.2 |
Additions | 27.3 | 21.2 |
Disposals | (1.6) | (1.3) |
Lease repayments | (18.5) | ( 19.9) |
Interest on lease liabilities (note 6) | 3.9 | 3.9 |
Transfers to Held for Sale Assets | — | (8.7) |
Exchange movements | 0.4 | (3.1) |
At 30 September | 83.8 | 72.3 |
Analysed as: | £m | £m |
Repayable within one year | 13.5 | 13.1 |
Repayable after one year | 70.3 | 59.2 |
| 2025 | 2024 | |
| £m | £m | |
At 1 October | (48.6) | (58.4) |
Credited to the Consolidated Income Statement (note 7) | 19.7 | 8.9 |
Acquisitions and disposals | (5.3) | (5.3) |
Accounted for in Other Comprehensive Income or directly in Equity | 0.1 | 2.5 |
Transfers to Held for Sale Assets | — | 1.2 |
Exchange adjustments | (1.1) | 2.5 |
At 30 September | (35.2) | (48.6) |
Assets | Liabilities | Net | ||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |
| £m | £m | £m | £m | £m | £m | |
Property, plant and equipment | 1.9 | — | (6.8) | ( 7.4) | (4.9) | (7.4) |
Goodwill and intangible assets | — | — | (61.1) | (60.8) | (61.1) | (60.8) |
| Retirement benefit | ||||||
assets/obligations | — | 0.1 | (0.4) | (0.4) | (0.4) | (0.3) |
Inventories | 11.6 | 5.8 | — | (0.3) | 11.6 | 5.5 |
| Share-based | ||||||
payments | 4.2 | 3.8 | — | — | 4.2 | 3.8 |
Leases | 2.0 | 1.7 | — | — | 2.0 | 1.7 |
| Other temporary | ||||||
differences | 13.7 | 9.3 | (0.3) | (0.4) | 13.4 | 8.9 |
33.4 | 20.7 | (68.6) | (69.3) | (35.2) | (48.6) | |
Deferred tax offset | (23.7) | (19.8) | 23.7 | 19.8 | — | — |
9.7 | 0.9 | (44.9) | (49.5) | (35.2) | (48.6) |
| 2025 | 2024 | |
| £m | £m | |
Finished goods at 30 September | 29 7.4 | 280.1 |
| 2025 | 2024 | |
| £m | £m | |
Trade receivables | 223.2 | 204.5 |
Less: loss allowance | (12.1) | (11.1) |
211.1 | 193.4 | |
Other receivables | 7.2 | 4.7 |
Prepayments and accrued income | 10.7 | 8.8 |
At 30 September | 229.0 | 206.9 |
| 2025 | 2024 | |
| £m | £m | |
UK sterling | 44.6 | 40.8 |
US dollars | 112.3 | 94.2 |
Canadian dollars | 19.0 | 22.3 |
Euros | 29.5 | 30.5 |
Other | 17.8 | 16.7 |
223.2 | 204.5 |
| 2025 | 2024 | |
| £m | £m | |
Not past due | 171.6 | 149.2 |
Past due | 39.5 | 44.2 |
Receivables impaired | 12.1 | 11.1 |
223.2 | 204.5 |
| 2025 | 2024 | |
| £m | £m | |
Up to one month past due | 29.9 | 31.3 |
Between one and two months past due | 5.5 | 8.2 |
Between two and four months past due | 2.5 | 3.1 |
Over four months past due | 1.6 | 1.6 |
39.5 | 44.2 |
| 2025 | 2024 | |
| £m | £m | |
At 1 October | 11.1 | 10.1 |
Charged/(credited) against profit, net | 1.2 | (0.6) |
Set up on acquisition | 0.2 | 2.1 |
Utilised by write-off | (0.4) | (0.5) |
At 30 September | 12.1 | 11.1 |
| 2025 | 2024 | |
| £m | £m | |
Trade payables | 120.5 | 108.6 |
Other payables | 34.5 | 17.6 |
Other taxes and social security | 13.7 | 12.3 |
Accruals and deferred income | 82.3 | 67.0 |
At 30 September | 251.0 | 205.5 |
| Analysed as: | ||
Payable within one year | 245.3 | 204.4 |
Payable after one year | 5.7 | 1.1 |
| 2025 | 2024 | |
| £m | £m | |
UK sterling | 26.3 | 23.0 |
US dollars | 58.3 | 54.0 |
Canadian dollars | 4.2 | 1.4 |
Euros | 26.4 | 25.4 |
Other | 5.3 | 4.8 |
120.5 | 108.6 |
| 2025 | 2024 | |||||||||||
| UK | US$ | C$ | Euro | Other | Total | UK | US$ | C$ | Euro | Other | Total | |
| £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
Cash at bank | 19.2 | 24.9 | 1.7 | 20.0 | 10.8 | 76.6 | 16.1 | 12.9 | 4.2 | 8.4 | 7.5 | 49.1 |
Short-term deposits | 3.3 | 0.5 | 0.5 | 0.1 | 0.7 | 5.1 | 2.5 | 0.6 | 0.1 | 2.5 | 0.7 | 6.4 |
At 30 September | 22.5 | 25.4 | 2.2 | 20.1 | 11.5 | 81.7 | 18.6 | 13.5 | 4.3 | 10.9 | 8.2 | 55.5 |
| Carrying amount | ||
| 2025 | 2024 | |
| £m | £m | |
Trade receivables (note 16) | 211.1 | 193.4 |
Other receivables (note 16) | 7. 2 | 4.7 |
Cash and cash equivalents (note 18) | 81.7 | 55.5 |
At 30 September | 300.0 | 253.6 |
| 2025 | 2024 | |
| £m | £m | |
Expiring within one year | — | — |
Expiring after one year (note 24) | 499.6 | 389.9 |
| 2025 | 2024 | |
| £m | £m | |
Trade payables (note 17) | 120.5 | 108.6 |
Other payables (note 17) | 34.5 | 17. 6 |
Lease liabilities (note 13) | 83.8 | 72.3 |
Other liabilities (note 20) | 26.7 | 25.4 |
Borrowings (note 24) | 381.1 | 479.8 |
646.6 | 703.7 | |
The maturities of the contractual undiscounted financial liabilities are as follows: | ||
Less than one year | 193.9 | 169.3 |
One to two years | 54.0 | 37.9 |
Two to five years | 140.4 | 256.9 |
More than five years | 419.1 | 418.4 |
807.4 | 882.5 |
| 2025 | 2024 | |
| £m | £m | |
| Decrease in adjusted operating profit (at average rates) | ||
US dollar: UK sterling | 24.6 | 16.4 |
Canadian dollar: UK sterling | 2.6 | 2.6 |
Euro: UK sterling | 4.0 | 4.1 |
| Decrease in total equity (at spot rates) | ||
US dollar: UK sterling | 17.3 | 12.7 |
Canadian dollar: UK sterling | 15.7 | 14.7 |
Euro: UK sterling | 6.1 | 8.4 |
| 2025 | 2024 | |
| £m | £m | |
Future purchases of minority interests | 5.5 | 9.0 |
Deferred consideration | 21.2 | 16.4 |
At 30 September | 26.7 | 25.4 |
| Analysed as: | ||
Due within one year | 10.9 | 8.8 |
Due after one year | 15.8 | 16.6 |
| 2025 | 2024 | |
| £m | £m | |
At 1 October | 9.0 | 9.2 |
Purchase of minority interest | (4.0) | — |
Exchange movements | 0.2 | (0.1) |
Fair value remeasurements | 0.3 | (0.1) |
At 30 September | 5.5 | 9.0 |
| Discount | Foreign | 30 Sep | |||||
| 1 Oct 2024 | Additions | unwind | Payments | Revaluation | exchange | 2025 | |
| £m | £m | £m | £m | £m | £m | £m | |
AHW | 1.4 | — | 0.1 | (0.8) | (0.7) | — | — |
AMG Sealing | 0.2 | — | — | (0.2) | — | — | — |
| Fluid Power | |||||||
Services | 0.5 | — | 0.1 | (0.2) | — | — | 0.4 |
Hedley | 0.8 | — | — | (0.4) | — | — | 0.4 |
GP&S | 0.7 | — | 0.1 | (0.8) | — | — | — |
Hex | 1.0 | — | 0.3 | (1.0) | (0.3) | — | — |
PTFE | 0.5 | — | 0.1 | (0.7) | 0.7 | — | 0.6 |
Fast Gaskets | 0.3 | — | — | (0.1) | — | — | 0.2 |
CTS | 1.3 | — | 0.2 | — | (1.1) | — | 0.4 |
Abbey Hose | 1.1 | — | 0.2 | (0.5) | (0.2) | — | 0.6 |
PAR | 1.4 | — | 0.3 | — | — | — | 1.7 |
Peerless | 7.2 | — | 1.6 | — | 4.9 | (0.2) | 13.5 |
R&G | — | 1.7 | — | — | (0.6) | — | 1.1 |
Viking | — | 0.2 | — | — | — | — | 0.2 |
Electramed | — | 1.6 | 0.1 | — | — | (0.1) | 1.6 |
Astro Industries | — | 0.5 | — | — | — | — | 0.5 |
16.4 | 4.0 | 3.1 | (4.7) | 2.7 | (0.3) | 21.2 |
| £m | |
At 1 October 2023 | 6.4 |
Share of profit | 0.7 |
Dividends paid | (0.4) |
At 30 September 2024 | 6.7 |
Share of profit | 0.6 |
Disposal of business | (0.5) |
Purchase of minority interest | (2.2) |
Dividends paid | (0.2) |
Exchange adjustments | 0.1 |
At 30 September 2025 | 4.5 |
Alpha Labs | Others | Total | ||||
| Book value | Fair value | Book value | Fair value | Book value | Fair value | |
| £m | £m | £m | £m | £m | £m | |
Acquisition intangible assets 1 | — | 11.0 | — | 16.3 | — | 27. 3 |
Deferred tax | 0.8 | (2.1) | (0.1) | (2.6) | 0.7 | (4.7) |
Investment | 1.2 | 1.2 | — | — | 1.2 | 1.2 |
Property, plant and equipment, and other intangible assets | 2.6 | 5.0 | 0.5 | 0.5 | 3.1 | 5.5 |
Inventories | 2.8 | 3.0 | 4.4 | 4.6 | 7.2 | 7.6 |
Trade and other receivables | 3.3 | 3.3 | 3.7 | 3.5 | 7.0 | 6.8 |
Trade and other payables | (2.8) | (3.1) | (5.0) | (5.7) | ( 7.8) | (8.8) |
Net assets acquired | 7.9 | 18.3 | 3.5 | 16.6 | 11.4 | 34.9 |
Goodwill | — | 9.2 | — | 12.0 | — | 21.2 |
Minority interests | — | — | — | — | — | — |
Cash paid 2 | 50.4 | 29.0 | 79.4 | |||
Cash and cash equivalents acquired | (22.9) | (2.7) | (25.6) | |||
27.5 | 26.3 | 53.8 | ||||
Deferred consideration | — | 2.3 | 2.3 | |||
Total investment | 27.5 | 28.6 | 56.1 |
| £m | |
Total investment | 56.1 |
Debt | (1.2) |
Net consideration | 54.9 |
| Pro forma | |||||||
| Adjusted | adjusted | ||||||
| Pro forma | operating | operating | |||||
| Acquisition | Revenue | Adjustments 1 | revenue | Profit | Adjustments 1 | Profit | |
| date | £m | £m | £m | £m | £m | £m | |
Viking Tapes | 18-Dec-24 | 2.8 | 0.9 | 3.7 | 0.1 | 0.1 | 0.2 |
Haagensen | 01-Jul-25 | 1.7 | 5.0 | 6.7 | 0.3 | 1.0 | 1.3 |
Alpha Labs | 07-Jul-25 | 5.7 | 17.2 | 22.9 | 1.2 | 3.5 | 4.7 |
Electramed | 21-Aug-25 | 0.6 | 4.7 | 5.3 | 0.1 | 1.1 | 1.2 |
Astro | 25-Sep-25 | 0.1 | 7.9 | 8.0 | — | 1.4 | 1.4 |
10.9 | 35.7 | 46.6 | 1.7 | 7.1 | 8.8 |
| 2025 | 2024 | |
| £m | £m | |
Operating profit | 283.7 | 207.4 |
Acquisition related and other charges (note 2) | 59.0 | 77.6 |
Adjusted operating profit | 342.7 | 285.0 |
Depreciation or amortisation of tangible, other intangible assets and leases – right-of-use assets (note 2) | 30.5 | 32.2 |
Share-based payments expense (note 5) | 6.2 | 7.1 |
Defined benefit pension scheme payments (note 25) | (0.1) | (0.5) |
Profit on disposal of assets | (0.1) | (1.9) |
Acquisition and disposal expenses paid | (10.6) | (30.2) |
Other non-cash movements | 6.5 | (3.5) |
Non-cash items and other | 32.4 | 3.2 |
Operating cash flow before changes in working capital | 375.1 | 288.2 |
Increase in inventories | ( 17.4) | (7.7) |
Increase in trade and other receivables | (14.7) | (18.5) |
Increase in trade and other payables | 2 7.5 | 17. 7 |
Increase in working capital | (4.6) | (8.5) |
Cash flow from operating activities | 370.5 | 279.7 |
| 2025 | 2024 | |
| £m | £m | |
Net increase/(decrease) in cash and cash equivalents | 23.4 | (6.4) |
Cash reclassified to assets held for sale | — | 4.7 |
Decrease/(increase) in borrowings | 113.3 | (183.9) |
136.7 | (185.6) | |
Effect of exchange rates and other non-cash movements | (16.5) | 20.7 |
Decrease/(increase) in net debt | 120.2 | (164.9) |
Net debt at beginning of year | (419.6) | (254.7) |
Net debt at end of year | (299.4) | (419.6) |
| Comprising: | ||
Cash and cash equivalents | 81.7 | 55.5 |
Cash and cash equivalents held in disposal groups | — | 4.7 |
| Bank borrowings: | ||
– Overdraft facilities | (0.9) | — |
– Revolving credit facility | (55.4) | (165.1) |
– Private placement notes | (329.6) | (319.8) |
– Capitalised borrowing fees | 4.8 | 5.1 |
(381.1) | (479.8) | |
Net debt at end of year | (299.4) | (419.6) |
| Analysed as: | ||
Repayable within one year | (0.9) | — |
Repayable after one year | (380.2) | (479.8) |
Face value | Rate | Maturity |
75m EUR | 4.18% | 2031 |
100m EUR | 4.27% | 2034 |
75m EUR | 4.38% | 2036 |
100m USD | 5.39% | 2032 |
50m USD | 5.52% | 2035 |
| 2025 | 2024 | |
| £m | £m | |
Diploma Holdings PLC UK Pension Scheme | 1.7 | 1.5 |
Kubo Pension Scheme | — | (1.0) |
Pension scheme net asset | 1.7 | 0.5 |
| 2025 | 2024 | |
| £m | £m | |
Diploma Holdings PLC UK Pension Scheme | 0.1 | 0.3 |
Kubo Pension Scheme | — | (0.3) |
Amounts credited to the Consolidated Income Statement | 0.1 | — |
| 2025 | 2024 | |
| £m | £m | |
| Market value of Scheme assets: | ||
Insured Assets 1 | 23.6 | 25.6 |
Cash and cash equivalents | 1.9 | 1.7 |
25.5 | 27.3 | |
Present value of Scheme liabilities | (23.8) | (25.8) |
Pension scheme net asset | 1.7 | 1.5 |
| 2025 | 2024 | |
| £m | £m | |
Charged to operating profit | — | — |
Interest cost on liabilities | (1.3) | (1.4) |
Interest on assets | 1.4 | 1.7 |
Credited to financial expense, net (note 6) | 0.1 | 0.3 |
Amounts credited to the Consolidated Income Statement | 0.1 | 0.3 |
| 2025 | 2024 | |
| £m | £m | |
Investment loss on Scheme assets in excess of interest | (2.1) | (5.3) |
Effect of changes in financial assumptions on Scheme liabilities | 2.1 | (1.1) |
Effect of changes in demographic assumptions on Scheme liabilities | — | 0.3 |
| Actuarial loss charged in the Consolidated Statement | ||
of Comprehensive Income | — | (6.1) |
| 2025 | 2024 | |
| £m | £m | |
Asset as at 1 October | 1.5 | 6.8 |
Amounts credited to the Consolidated Income Statement | 0.1 | 0.3 |
Contributions paid by employer | — | 0.5 |
Expenses paid | 0.1 | — |
Net effect of remeasurements of Scheme assets and liabilities | — | (6.1) |
Asset as at 30 September | 1.7 | 1.5 |
| 2025 | 2024 | |
| £m | £m | |
At 1 October | 25.8 | 24.8 |
Interest cost on liabilities | 1.3 | 1.4 |
Impact from changes in demographic assumptions | — | (0.3) |
Impact from changes in actuarial assumptions | (2.1) | 1.1 |
Benefits paid | (1.2) | (1.2) |
At 30 September | 23.8 | 25.8 |
| 2025 | 2024 | |
| £m | £m | |
At 1 October | 27.3 | 31.6 |
Interest on assets | 1.4 | 1.7 |
Return on Scheme assets | (2.1) | (5.3) |
Contributions paid by employer | — | 0.5 |
Expenses paid | 0.1 | — |
Benefits paid | (1.2) | (1.2) |
At 30 September | 25.5 | 27.3 |
| 2025 | 2024 | |
| % | % | |
Cash and cash equivalents | 7 | 6 |
Insured Assets | 93 | 94 |
| 2025 | 2024 | 2023 | 2022 | ||
| % | % | % | % | ||
Inflation rate | – RPI | 3.1 | 3.2 | 3.4 | 3.6 |
– CPI | 2.7 | 2.8 | 3.0 | 3.2 | |
Expected rate of pension increases | – CPI | 2.7 | 2.7 | 3.0 | 3.2 |
Discount rate | 5.8 | 5.1 | 5.6 | 5.3 |
Mortality table used: | S3PA |
Year the mortality table was published: | CMI 2024 |
| Allowance for future improvements | Year of birth projections, with a long-term |
| in longevity: | improvement rate of 1.0% |
| Allowance made for members to take | Members are assumed to take 0% of their |
| a cash lump sum on retirement: | maximum cash sum (based on current |
The weighted average duration of the defined benefit obligation is around | commutation factors) |
| 14 years (2024: 14 years) |
| Impact on pension | |||
| liabilities | |||
| Estimated | Estimated | ||
| increase | increase | ||
Factor | Assumption | % | £m |
Discount rate | Decrease by 0.5% | 6.3 | 1.5 |
Inflation | Increase by 0.5% | 3.4 | 0.8 |
Life expectancy | Increase by one year | 2.9 | 0.7 |
| 2025 | 2024 | |
| £m | £m | |
Assets of the Kubo Scheme 1 | — | 14.9 |
Actuarial liabilities of the Kubo Scheme | — | (15.9) |
Pension scheme net deficit | — | (1.0) |
| 2025 | 2024 | |
| £m | £m | |
Service cost | — | (0.3) |
Amount charged to operating profit in the Consolidated Income Statement | — | (0.3) |
| 2025 | 2024 | |
| £m | £m | |
Investment (loss)/gain on Scheme assets in excess of interest | (0.2) | 0.8 |
Effect of changes in financial assumptions on Scheme liabilities | — | (1.9) |
Experience adjustments on Scheme liabilities | — | 0.2 |
| Actuarial loss charged in the Consolidated Statement | ||
of Comprehensive Income | (0.2) | (0.9) |
2025 | 2024 | |
Expected rate of pension increase | 0% | 0% |
Expected rate of salary increase | 1.3% | 1.3% |
Discount rate | 1.1% | 1.1% |
Interest credit rate | 1.3% | 1.3% |
Mortality | BVG2020 | BVG2020 |
| 2025 | 2024 | |
| £m | £m | |
At 1 October | (1.0) | (0.3) |
Amounts charged to the Consolidated Income Statement | — | (0.3) |
Contributions paid by employer | — | 0.5 |
Disposal | 1.2 | — |
Net effect of remeasurements of Kubo Scheme assets and liabilities | (0.2) | (0.9) |
At 30 September | — | (1.0) |
| 2025 | 2024 | |
| £m | £m | |
| Fees payable to the auditors for the audit of: | ||
– the Company’s Annual Report and Accounts | 1.3 | 1.5 |
– the Company’s subsidiaries | 0.4 | 0.4 |
Audit fees | 1.7 | 1.9 |
Average | Closing | |||
2025 | 2024 | 2025 | 2024 | |
US dollar (US$) | 1.31 | 1.27 | 1.35 | 1.34 |
Canadian dollar (C$) | 1.83 | 1.73 | 1.87 | 1.81 |
Euro (€) | 1.18 | 1.17 | 1.15 | 1.20 |
Swiss franc (CHF) | 1.11 | 1.12 | 1.07 | 1.13 |
Australian dollar (AUD) | 2.04 | 1.92 | 2.03 | 1.93 |
£m | % | |
| September 2024 Reported revenue (basis for Acquisitions and | ||
Disposals / Exchange rates impacts) | 1,363.4 | |
Acquisitions and Disposals 1 | 35.0 | 3 |
Basis for organic growth impact | 1,398.4 | |
Organic growth 2 | 159.8 | 11 |
Exchange rates 3 | (33.7) | (2) |
September 2025 Reported revenue | 1,524.5 |
| 2025 | 2024 | ||
| Note | £m | £m | |
Revenue | 1,524.5 | 1,363.4 | |
Operating profit as reported under UK-adopted IAS | 283.7 | 207.4 | |
Add: Acquisition related and other charges | 2 | 59.0 | 77.6 |
Adjusted operating profit | 3 | 342.7 | 285.0 |
Adjusted operating margin | 22.5% | 20.9% |
| 2025 | 2024 | ||
| Note | £m | £m | |
Net increase/(decrease) in cash and cash equivalents | 23.4 | (6.4) | |
Add: Dividends paid to shareholders and minority interests | 80.9 | 77.2 | |
| Acquisition of minority interests | 0.8 | — | |
Acquisition/disposal of businesses (including net expenses) | 24.1 | 300.7 | |
Acquisition related deferred payments/receipts, net | 4.7 | 10.3 | |
| Net repayments of/(proceeds from) borrowings (including | |||
borrowing fees) | 113.3 | (183.9) | |
Free cash flow | 247.2 | 197.9 | |
Adjusted earnings 1 | 9 | 236.0 | 195.4 |
Free cash flow conversion | 105% | 101% |
| 2025 | 2024 | ||
| Note | £m | £m | |
Cash and cash equivalents | 18 | 81.7 | 55.5 |
Cash and cash equivalents held in disposal groups | 24 | — | 4.7 |
Borrowings | 24 | (381.1) | (479.8) |
Retranslation at average exchange rates | 0.9 | (3.5) | |
Net debt at average exchange rates | (298.5) | (423.1) | |
Adjusted operating profit | 29.2 | 342.7 | 285.0 |
Depreciation and amortisation of tangible and other intangible assets | 2 | 15.0 | 15.9 |
IFRS 16 impact | (2.1) | (3.6) | |
Minority interest share of adjusted operating profit | (0.8) | (0.9) | |
Pro forma adjustments 1 | 5.8 | 39.1 | |
EBITDA | 360.6 | 335.5 | |
Leverage | 0.8x | 1.3x |
| 2025 | 2024 | ||
| Note | £m | £m | |
Net assets as reported under UK-adopted IAS | 994.2 | 894.7 | |
| Add/(deduct): | |||
– Deferred tax liabilities, net | 14 | 35.2 | 48.6 |
– Retirement benefit assets, net | 25 | (1.7) | (1.5) |
– Acquisition related liabilities/assets, net | 24.7 | 23.6 | |
– Net debt | 24 | 299.4 | 419.6 |
Trading capital employed | 1,351.8 | 1,385.0 | |
– Historic goodwill and acquisition related charges, net of deferred tax and currency movements | 309.6 | 308.0 | |
Adjusted trading capital employed | 1,661.4 | 1,693.0 | |
Adjusted operating profit | 29.2 | 342.7 | 285.0 |
Pro forma adjustments 1 | 5.2 | 38.9 | |
Pro forma adjusted operating profit | 347.9 | 323.9 | |
ROATCE | 20.9% | 19.1% |
Freehold property | • between 20 and 50 years |
Leasehold improvements | • term of the lease |
Plant and equipment | • plant and machinery between 3 and 7 years |
| • IT hardware between 3 and 5 years | |
| • fixtures and fittings between 5 and 15 years | |
Hospital field equipment | • 5 years |